跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norketotifen
首页
药物
Norketotifen
Norketotifen
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
NORKETOTIFEN FOR USE IN THE TREATMENT OF RESPIRATORY DISORDERS
EP 3927428 C0
申请人: BRIDGE PHARMA INC
优先权: 2019
EP
US
WO
5 件公开
Optically active isomers of ketotifen and therapeutically active metabolites thereof
US 7226934 B1
申请人: BRIDGE PHARMA INC
优先权: 2000
US
5 件公开
OCULAR FORMULATIONS OF NORKETOTIFEN
US 2010130550 A1
申请人: BRIDGE PHARMA INC
优先权: 2009
US
4 件公开
Methods of treatment of histamine H-4 receptor-related pruritus
US 9138431 B2
申请人: BRIDGE PHARMA INC
优先权: 2013
US
3 件公开
Treating xerophthalmia with norketotifen
US 8741930 B2
申请人: ABERG A K GUNNAR
优先权: 2008
US
2 件公开
Medicinal treatment of dermal diseases in companion animals
US 8778971 B2
申请人: ABERG A K GUNNAR
优先权: 2013
US
2 件公开
Methods of treatment of asthma and COPD
US 10959992 B2
申请人: BRIDGE PHARMA INC
优先权: 2020
US
2 件公开
Medicinal treatment of dermal diseases in dogs
US 8557846 B1
申请人: BRIDGE PHARMA INC
优先权: 2013
US
Methods of treatment of non-histaminic pruritus
US 9345697 B2
申请人: BRIDGE PHARMA INC
优先权: 2015
US
Medicinal treatment of dermal infectious disorders with norketotifen
US 9808419 B2
申请人: BRIDGE PHARMA INC
优先权: 2016
US
第 1 / 2 页
上一页
下一页
药物
反馈